# PRODUCT INTAKE — LIVE PROJECT LEDGER

**Project:** HBI — Health & Beauty Intelligence  
**Domain:** Product Intake  
**Source of Truth:** GitHub `master`  
**Owner:** Product Owner / Domain Architect  
**Last Reconciled:** 2026-09-25  
**Reality baseline:** `96fa13853edb9f3eb13fa7455920640f50049a45`

---

# 1. CURRENT POSITION

**CURRENT PHASE:** REALITY / GAP RECONCILIATION

**CURRENT STATUS:** ACTIVE — Mission 1 corrected; Mission 2 and Mission 3 running.

**IMPLEMENTATION AUTHORIZED:** NO

**CURRENT OBJECTIVE:**
Produce one reconciled Product Intake 0→100 GAP map from GitHub evidence before selecting an implementation WP.

---

# 2. VERIFIED LANDED CAPABILITIES

Current master contains and has evidence for:

- Product identity and P4 lifecycle / QA governance;
- G1 Duplicate Check;
- G2 Research Draft with source-traceable assertions;
- G4 Evidence governance parity;
- G5 Recommendation Evidence Trust Trace;
- ProductKnowledge and Evidence boundaries;
- Product Intake UI/API;
- governed ACTIVE → Recommendation integration.

Research Draft is a real capability, but it is a **minimal assertion orchestration boundary**, not the complete AI Research / Research Dossier system.

---

# 3. CORRECTED REALITY

The following distinctions are now locked for this reconciliation:

- Research Draft = IMPLEMENTED.
- Assertion classification = IMPLEMENTED.
- Evidence/provenance/conflict/UNKNOWN governance = IMPLEMENTED foundation.
- AI Research acquisition/orchestration = GAP.
- Composition/INCI = PARTIAL.
- Ingredient Roles = PARTIAL.
- Functional Information = PARTIAL.
- Suitability = PARTIAL.
- Safety = PARTIAL.
- Usage = PARTIAL.
- Commercial Information = PARTIAL.
- Source Comparison = OPEN.
- PO Review surface = PARTIAL/GAP.
- Re-validation workflow = GAP with OPEN trigger policy.
- End-to-end Intake UI orchestration = GAP.

---

# 4. HISTORICAL SCOPE PRESERVED

The Strategy explicitly includes:

- full INCI / ingredient list;
- ingredient roles;
- formulation information;
- intended uses;
- manufacturer claims;
- claimed benefits;
- product characteristics;
- skin/hair suitability and unsuitable cases where supported;
- limitations, precautions, contraindications, interactions, risks;
- manufacturer instructions and usage guidance;
- evidence quality/strength, sources and dates;
- price/reference price, availability, market position, demand indicators;
- source comparison;
- UNKNOWN and CONFLICT preservation.

These are historical Product Intake scope, not newly invented requirements.

---

# 5. OPEN DECISIONS

Remain OPEN until PO decision:

- duplicate matching algorithm details;
- source-tier taxonomy detail;
- AI research tier/cost/model;
- Product / Variant / SKU technical model;
- provisional/shadow mechanism;
- dedicated research-dossier schema;
- re-validation trigger matrix;
- complex history/version schema beyond ProductMutationLog;
- default inventory behaviour for non-ACTIVE products;
- structured retention/representation of source comparisons.

No implementation should silently close an OPEN decision.

---

# 6. CURRENT GAP ORDER

The management order is dependency-first, not majority-vote:

**GAP-A — Intake orchestration boundary**  
Connect existing introduction and duplicate/research/enrichment/review capabilities into one governed flow, subject to the OPEN duplicate-before-create policy.

**GAP-B — Complete Product Research Dossier / enrichment**  
Close the information-domain gaps without replacing existing Evidence/Knowledge governance.

**GAP-C — AI Research acquisition/orchestration**  
Design and implement actual AI-assisted source acquisition only after provenance and governance boundaries are explicit.

**GAP-D — PO full-dossier review surface**  
Expose the complete dossier, evidence, UNKNOWN/CONFLICT and P4 actions coherently.

**GAP-E — Re-validation**  
Close trigger policy first, then implement the governed re-validation workflow.

**GAP-F — Real Product Pilot / G8**  
Verify the complete path on real products with A–D protection and downstream continuity.

This order is a **management sequence**, not a ranking of political or personal choices; it may change after the cross-audit if GitHub evidence establishes a dependency.

---

# 7. WORKING RULE

Every completed work unit records:

- date;
- exact baseline SHA;
- objective;
- files/symbols;
- tests/CI;
- final SHA;
- acceptance result;
- remaining limitations;
- next action.

No report is accepted as repository reality without GitHub evidence.

---

# 8. CURRENT NEXT ACTION

Wait for Mission 2 and Mission 3 evidence, then perform the final independent reconciliation against `master`.

After reconciliation:

**ONE named WP → PO authorization → implementation → CI → post-merge Reality Gate.**

# END
